Expanded newborn screening in the Health Services of the Mexican Navy

In Mexico the birth prevalence of the metabolic diseases detected by expanded newborn screening is poorly known and there is little information about its performance indicators.Objective. Describe the birth prevalence of the metabolic defects detected by the expanded newborn screening program implem...

Full description

Saved in:
Bibliographic Details
Main Authors: Max Trigo-Madrid (Author), Javier Díaz-Gallardo (Author), Roberto Mar-Aldana (Author)
Format: Book
Published: Instituto Nacional de Pediatría, 2014-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_09a281c8a8f64e77ac07c828a2f3669e
042 |a dc 
100 1 0 |a Max Trigo-Madrid  |e author 
700 1 0 |a Javier Díaz-Gallardo  |e author 
700 1 0 |a Roberto Mar-Aldana  |e author 
245 0 0 |a Expanded newborn screening in the Health Services of the Mexican Navy 
260 |b Instituto Nacional de Pediatría,   |c 2014-11-01T00:00:00Z. 
500 |a 0186-2391 
500 |a 2395-8235 
500 |a 10.18233/APM35No6pp448-458 
520 |a In Mexico the birth prevalence of the metabolic diseases detected by expanded newborn screening is poorly known and there is little information about its performance indicators.Objective. Describe the birth prevalence of the metabolic defects detected by the expanded newborn screening program implemented in the Mexican Navy (Secretaría de Marina Armada de México, SEMAR), and to make known some of its performance indicators. Materials and Methods. A blood sample of 5 205 newborns from 18 Mexican states were taken. The age at blood sampling, the proportion of samples taken between the 3rd and the 5th days of life, and the time of results delivery were analyzed. The number and type of detected metabolic diseases, as well as the maternal age and body mass index, the type of birth, the gestational age and weight of the newborns were analized. Results. The age at blood sampling was 4.7 days and 81.15 percent of the samples were obtained in optimal time. Two cases of congenital hypothyroidism (3.8/10 000 newborns), one of adrenal congenital hyperplasia (1.9/10 000 newborns) and five cases of deficiency of glucose- 6-phosphate dehydrogenase (9.6/10 000 newborns) were detected. The 85.6% of mothers had pregnancies at an optimal reproductive age (20-35 years), but overweight and obesity occurred in 44.7% of them. Conclusions. In this analyzed population, the birth prevalence of metabolic defects was 15.37/10 000 newborns. The expanded newborn screening program allowed its identification and timely treatment, with the aim of preventing disability and death. 
546 |a ES 
690 |a tamiz neonatal 
690 |a defectos al nacimiento 
690 |a enfermedades metabólicas 
690 |a errores innatos del metabolismo 
690 |a prevención y control 
690 |a Medicine 
690 |a R 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Acta Pediátrica de México, Vol 35, Iss 6, Pp 448-458 (2014) 
787 0 |n http://ojs.actapediatrica.org.mx/index.php/APM/article/view/875 
787 0 |n https://doaj.org/toc/0186-2391 
787 0 |n https://doaj.org/toc/2395-8235 
856 4 1 |u https://doaj.org/article/09a281c8a8f64e77ac07c828a2f3669e  |z Connect to this object online.